pyridostigmine bromide has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habermann, TM; O'Neill, BP; Salomao, DR; Vernino, S | 1 |
| Ogilvy-Stuart, AL; Shalet, SM; Wallace, WH | 1 |
2 other study(ies) available for pyridostigmine bromide and Brain Neoplasms
| Article | Year |
|---|---|
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brain Neoplasms; Cell Transformation, Neoplastic; Drug Therapy, Combination; Female; Frontal Lobe; Humans; Immunity, Cellular; Immunosuppressive Agents; Lymphoma, B-Cell; Magnetic Resonance Imaging; Myasthenia Gravis; Mycophenolic Acid; Parietal Lobe; Prednisone; Pyridostigmine Bromide; Rituximab; T-Lymphocytes; Treatment Outcome | 2005 |
Radiation and neuroregulatory control of growth hormone secretion.
Topics: Adult; Brain Neoplasms; Cranial Irradiation; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Peptide Fragments; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1994 |